NCT01820325View on ClinicalTrials.gov

Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 9, 2013

Primary Completion Date

June 18, 2014

Study Completion Date

June 18, 2014

Conditions
Non-Small Cell Lunch Cancer
Interventions
DRUG

Buparlisib

DRUG

Buparlisib placebo

Placebo + Carboplatin + Paclitaxel

DRUG

Carboplatin

DRUG

Paclitaxel

Trial Locations (7)

28046

Novartis Investigative Site, Madrid

72703

Highlands Oncology Group, Fayetteville

80131

Novartis Investigative Site, Napoli

89081

Novartis Investigative Site, Ulm

97210

Northwest Cancer Specialists Compass Oncology -BKM, Portland

M5G 1Z6

Novartis Investigative Site, Toronto

08035

Novartis Investigative Site, Barcelona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY